Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.08
-0.49 (-4.59%)
Oct 30, 2026, 12:48 PM EDT - Market open
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $896.28 million as of October 30, 2026. It is the 10,307th most valuable company in the world and the 2,284th biggest in the United States. Its market cap has increased by 0.65% in one year.
Market Cap
896.28M
Enterprise Value
401.71M
1-Year Change
0.65%
Global Rank
Country Rank
#2,284 United States
Category
ChartMarket Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $896.28M, an increase of 688.28%. That is a compound annual growth rate of 20.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 896.28M | -0.87% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 985.59M |
| Odyssey Therapeutics | 981.61M |
| Rigel Pharmaceuticals | 955.85M |
| Aktis Oncology | 952.21M |
| Obsidian Therapeutics | 951.30M |
| Monte Rosa Therapeutics | 946.13M |
| MeiraGTx Holdings | 944.10M |
| Alto Neuroscience | 942.60M |